Global Skin Cancer Diagnostics and Therapeutics Market Share - Segmented by Cancer Type, Process (Diagnosis and Treatment), and Geography - Growth, Trends, and Forecast (2022 - 2030)

Detailed TOC of Global Skin Cancer Diagnostics and Therapeutics Market Share - Segmented by Cancer Type, Process (Diagnosis and Treatment), and Geography - Growth, Trends, and Forecast (2022 - 2030)

1. Introduction

                1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

                5.1 Current Market Scenario

                5.2 Porter's Five Forces Analysis

                                5.2.1 Bargaining Power of Suppliers

                                5.2.2 Bargaining Power of Consumers

                                5.2.3 Threat of New Entrants

                                5.2.4 Threat of Substitute Product and Services

                                5.2.5 Competitive Rivalry within the Industry

6. Market Dynamics

                6.1 Skin Cancer Diagnostics and Therapeutics Market Drivers

                                6.1.1 Increasing Incidences of Skin Cancer

                                6.1.2 Novel Immunotherapies and Label Extension of Current Therapies into New Settings     

                                6.1.3 Government Initiatives    

                6.2 Skin Cancer Diagnostics and Therapeutics Market Restraints

                                6.2.1 Lack of Awareness about Skin Cancer

                                6.2.2 High Cost Associated with Therapy

                                6.2.3 Stringent Regulatory Enviornment

                6.3 Skin Cancer Diagnostics and Therapeutics Market Opportunities

                6.4 Skin Cancer Diagnostics and Therapeutics Market Challenges

7. Market Segmentation

                7.1 Skin Cancer Diagnostics and Therapeutics Market By Cancer Type

                                7.1.1 Basal Cell Carcinoma

                                7.1.2 Squamous Cell Carcinoma

                                7.1.3 Melanoma

                7.2 Skin Cancer Diagnostics and Therapeutics Market By Process

                                7.2.1 Diagnosis  

                                                7.2.1.1 Dermatoscopy  

                                                7.2.1.2 Skin Biopsy

                                                7.2.1.3 Lymph Node Biopsy

                                                7.2.1.4 Imaging Tests

                                                7.2.1.5 Blood Test

                                                7.2.1.6 Optical Biopsy

                                7.2.2  Treatment 

                                                7.2.2.1 Chemotherapy 

                                                7.2.2.2 Radiotherapy   

                                                7.2.2.3 Cryosurgery

                                                7.2.2.4 Immune Therapy  

                                                7.2.2.5 Photodynamic Therapy

                                                7.2.2.6 Surgery

                                                7.2.2.7 Other Treatments

                7.3 Skin Cancer Diagnostics and Therapeutics Market By Geography

                                7.3.1 North America

                                                7.3.1.1 United States

                                                7.3.1.2 Canada

                                                7.3.1.3 Mexico

                                7.3.2 Europe

                                                7.3.2.1 France

                                                7.3.2.2 Germany

                                                7.3.2.3 United Kingdom

                                                7.3.2.4 Italy

                                                7.3.2.5 Spain

                                                7.3.2.6 Rest of Europe

                                7.3.3 Asia-Pacific

                                                7.3.3.1 China

                                                7.3.3.2 Japan

                                                7.3.3.3 India

                                                7.3.3.4 Australia

                                                7.3.3.5 South Korea

                                                7.3.3.6 Rest of Asia-Pacific

                                7.3.4 Middle East & Africa

                                                7.3.4.1 GCC

                                                7.3.4.2 South Africa

                                                7.3.4.3 Rest of the Middle East & Africa

                                7.3.5 South America

                                                7.3.5.1 Brazil

                                                7.3.5.2 Argentina

                                                7.3.5.3 Rest of South America

8. Skin Cancer Diagnostics and Therapeutics Market Key Players and Competitive Landscape

                8.1 Abbott Inc.

                8.2 Agilent Technologies Inc.  

                8.3 AstraZeneca PLC

                8.4 Bristol-Myers Squibb Co.   

                8.5 Eli Lilly and Co.

                8.6 GlaxoSmithKline PLC  

                8.7 Merck & Co. Inc.

                8.8 Novartis AG

                8.9 Pfizer Inc.

                8.10 Qiagen NV

                8.11 F. Hoffmann-La Roche AG

                8.12 Sanofi SA

                8.13 List Not Exhaustive

9. Future of the Skin Cancer Diagnostics and Therapeutics Market